ANI Pharmaceuticals
ANIP
$65.36
Share price
0.63%
Change (1 day)
75.27%
Change (1 year)
Categories
ANI Pharmaceuticals (ANIP) - Cash on Hand
Cash on Hand as of December 2023 : $0.22 B
According to ANI Pharmaceuticals's latest financial reports the company has $0.22 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
ANI Pharmaceuticals - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.22 B | 358.49% |
| 2022-12-31 | $48.22 M | -51.92% |
| 2021-12-31 | $0.10 B | 1175.43% |
| 2020-12-31 | $7.86 M | -87.38% |
| 2019-12-31 | $62.33 M | 44.93% |
| 2018-12-31 | $43 M | 38.09% |
| 2017-12-31 | $31.14 M | 13.81% |
| 2016-12-31 | $27.36 M | -82.31% |
| 2015-12-31 | $0.15 B | -8.49% |
| 2014-12-31 | $0.16 B | 1422.17% |
| 2013-12-31 | $11.1 M | -68.08% |
| 2012-12-31 | $34.79 M | -39.2% |
| 2011-12-31 | $57.22 M | 49.98% |
| 2010-12-31 | $38.15 M | 27.79% |
| 2009-12-31 | $29.85 M | 101.92% |
| 2008-12-31 | $14.78 M | -51.76% |
| 2007-12-31 | $30.65 M | 167.73% |
| 2006-12-31 | $11.44 M | 25.8% |
| 2005-12-31 | $9.1 M | -47.29% |
| 2004-12-31 | $17.26 M | 89.05% |
| 2003-12-31 | $9.13 M | 87.04% |
| 2002-12-31 | $4.88 M | 8.47% |
| 2001-12-31 | $4.5 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $13.96 B | 6,214.19% | 🇨🇭 Switzerland |
 Pfizer PFE | $12.69 B | 5,638.94% | 🇺🇸 USA |
 Cardinal Health CAH | $4.59 B | 1,976.24% | 🇺🇸 USA |
 Jazz Pharmaceuticals JAZZ | $1.62 B | 635.48% | 🇮🇪 Ireland |
 Evoke Pharma
EVOK | $4.73 M | -97.86% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $0.42 B | 91.57% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $3.22 B | 1,358.93% | 🇮🇱 Israel |
 Royalty Pharma RPRX | $1.23 B | 457.95% | 🇬🇧 UK |
 Lannett Company LCI | $46.54 M | -78.95% | 🇺🇸 USA |